Skip to main content
SpringerLink
Log in

Relevance of the T cell receptor for immunotherapy of cancer

  • Review
  • T Cell Receptor, Immunotherapy
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aebersold P, Hyatt C, Johnson S, Hines K, Korcak L, Sanders M, Lotze M, Topalian S, Yang J, Rosenberg SA (1991) Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J Natl Cancer Inst 83: 932

    Google Scholar 

  2. Alt FW, Oltz EM, Young F, Gorman J, Taccioli G, Chen J (1992) VDJ recombination. Immunol Today 13: 306

    PubMed  Google Scholar 

  3. Anichini A, Fossati G, Parmiani G (1985) Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer 35: 683

    PubMed  Google Scholar 

  4. Atzpodien J, Korfer A, Franks CR, Poliwoda H, Kirchner H (1990) Home therapy with recombinant interleukin 2 and interferon alpha 2b in advanced human malignancies. Lancet 335: 1509

    PubMed  Google Scholar 

  5. Aulitsky W, Gastl G, Aulitsky WE, Herold M, Kemmler J, Mull B, Frick J, Huber C (1989) Successful treatment of metastatic renal cell carcinoma with a biologic active dose of recombinant interferon gamma. J Clin Oncol 7: 1875

    PubMed  Google Scholar 

  6. Baniyas M, Garcia-Morales P, Bonifacino JS, Samelson LE, Klausner RD (1988) Disulfide linkage of the zeta and eta chains of the T cells receptor. Possible identification of two structural classes of receptors. J Biol Chem 263: 9874

    PubMed  Google Scholar 

  7. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumorassociated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86: 7159

    PubMed  Google Scholar 

  8. Benoist C, Mathis D (1992) Generation of the alpha beta T cell repertoire. Curr Opin Immunol 4: 156

    PubMed  Google Scholar 

  9. Berd D, Maguire HC, McCue P, Mastrangelo M (1990) Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients. J Clin Oncol 8: 1858

    PubMed  Google Scholar 

  10. Bergmann L, Weidmann E, Mitrou PS, Runne U, Keiholz U, Bartsch HN, Frank CR (1990) Interleukin 2 in combination with interferon alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II study. Onkologie 13: 137

    PubMed  Google Scholar 

  11. Bergmann L, Fenchel K, Weidmann E, Enzinger HM, Jahn B, Jonas D, Mitrou PS (1993) Daily alternating administration of high-dose interferon alpha and interleukin 2 bolus infusion in metastatic renal cell cancer. A phase II study. Cancer 72: 1733

    PubMed  Google Scholar 

  12. Berke G (1991) T-cell mediated cytotoxicity. Curr Opin Immunol 3: 320

    PubMed  Google Scholar 

  13. Berke G, Rosen D, Ronen D (1993) Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes. Immunology 78: 105

    PubMed  Google Scholar 

  14. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) The foreign antigen binding site and T-cell recognition regions of class 1 histocompatibility antigens. Nature 332: 512

    Google Scholar 

  15. Boitel B, Ermonval M, Panina-Bordingnon P, Mariuzza RA, Lanzavecchia A, Acuto O (1992) Preferential usage and lack of junctional sequence conservation among human T cell receptors specific for tetanus toxin-derived peptide. Evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J Exp Med 175: 765

    PubMed  Google Scholar 

  16. Boon T (1993) Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy. Int J Cancer 54: 177

    PubMed  Google Scholar 

  17. Brenner MC, Strominger JL, Krangel MS (1992) The gamma/delta T cell receptor. Adv Immunol 51: 85

    PubMed  Google Scholar 

  18. Brocker EB, Kolde G, Steinhausen D, Peters A, Macher E (1984) The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas. J Cancer Res Clin Oncol 107: 48

    PubMed  Google Scholar 

  19. Carrel S, Isler P, Schreger M, Vacca A, Salvi S, Giuffre L, Madi PJ-P (1986) Expression on human thymocytes of the idiotypic structures (Ti) from two leukemiz T cell lines. Jurkat and HPB-ALL. Eur J Immunol 16: 649

    PubMed  Google Scholar 

  20. Chatila T, Geha RS (1992) Superantigens. Curr Opin Immunol 4: 74

    PubMed  Google Scholar 

  21. Chen ME, Bander NH, Aulitzky W, Gastl GA (1993) Variability in the T cell receptor V alpha usage in human renal cell carcinoma (abstract 2723). Proc Am Assoc Cancer Res 34: 456

    Google Scholar 

  22. Choi YW, Kotzin B, Herron L, Callahan J, Marrack P, Kappler J (1989) Interaction ofStaphylococcus aureus toxin “super-antigens” with human T cells. Proc Natl Acad Sci USA 86: 8941

    PubMed  Google Scholar 

  23. Choi YW, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J (1990) Residues of the variable region of the T cell receptor beta chain that interact withS. aureus toxin superantigens. Nature 346: 471

    PubMed  Google Scholar 

  24. Choita C, Boswell DR, Lesk AM (1988) The outline structure of the T cell receptor. EMBO J 7: 3745

    PubMed  Google Scholar 

  25. Chou L, Ashe S, Brady WA, Hellstrom J, Hellstrom KE, Linsley PS (1992) Co-stimulation of antitumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71: 1093

    PubMed  Google Scholar 

  26. Chou T, Chang AE, Shu SY (1988) Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity. J Immunol 140: 2453

    PubMed  Google Scholar 

  27. Clevers H, Alacron B, Willeman T, Terhorst C (1988) The T cell receptor/CD3 complex: A dynamic protein ensemble. Annu Rev Immunol 6: 629

    PubMed  Google Scholar 

  28. Concannon P, Pickering LA, Kung P, Hood L (1986) Diversity and structure of the human T cell receptor beta-chain variable region genes. Proc Natl Acad Sci USA 83: 6598

    PubMed  Google Scholar 

  29. Dahiya R, Kwak KS, Byrd JC, Ho S, Yoon WH, Kim YS (1993) Mucin synthesis and expression in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res 53: 1437

    PubMed  Google Scholar 

  30. Damle NK, Doyle LV, Bradley EC (1986) Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors. J Immunol 137: 2814

    PubMed  Google Scholar 

  31. Darrow TL, Slingluff CL Jr, Siegler HF (1989) The role of HLA class I antigens in recognition of melanoma cells by tumorspecific cytotoxic T lymphocytes. J Immunol 142: 3329

    PubMed  Google Scholar 

  32. Davies TE, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A (1991) Evidence of limited variability of antigen receptors on intrathyroidal T cells in autoimmune thyroid disease. N Engl J Med 325: 238

    PubMed  Google Scholar 

  33. Davis LS, Oppenheimer-Marks N, Bednarezyk JL, McIntyre BW, Lipsky PE (1990) Fibronectin promotes proliferation of naive and memory T cells by signalling through VLA4 and VLA5 integrin molecules. J Immunol 145: 785

    PubMed  Google Scholar 

  34. Degiovanni G, Lahaye T, Herin M, Hainaut P, Boon T (1988) Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones. Eur J Immunol 18: 671

    PubMed  Google Scholar 

  35. Depuis M, Schaerer E, Krause KH, Tschopp J (1973) The calcium binding protein calreticulin is a major constituent of lytic granules in cytolytic T lymphocytes. J Exp Med 177: 1

    Google Scholar 

  36. Dohlsten M, Hedlund G, Kalland T (1991) Staphylococcal-enterotoxin-dependent cell-mediated cytotoxicity. Immunol Today 12: 147

    PubMed  Google Scholar 

  37. Dyson PJ, Knight AM, Fairchild S, Simpson E, Tomonari K (1991) Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumor virus genomes. Nature 349: 531

    PubMed  Google Scholar 

  38. Ferradini L, Roman-Roman S, Azocar J, Michalaki H, Triebel F, Hercend T (1991) Studies on the human T cell receptor alpha beta variable region genes. II. Identification of four additional V beta subfamilies. Eur J Immunol 21: 935

    PubMed  Google Scholar 

  39. Ferradini L, Roman SR, Azocar J, Aviril MF, Viel S, Triebel F, Hercend T (1992) Analysis of T-cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis. Cancer Res 52: 4649

    PubMed  Google Scholar 

  40. Ferradini L, Mackensen A, Genevee C, Bosq J, Duvillard P, Avril MF, Hercend T (1993) Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. J Clin Invest 91: 1183

    PubMed  Google Scholar 

  41. Ferrini S, Miescher S, Zocchi MR, Von Fliedner V, Moretta A (1987) Phenotypic and functional characterization of recombinant interleukin 2 (rIL-2)-induced act ivated killer cells: analysis at the population and clonal level. J Immunol 138: 1297

    PubMed  Google Scholar 

  42. Finke JH, Rayman P, Edinger M, Tubbs RR, Stanley J, Klein E, Bukowski R (1992) Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line. J Immunol 11: 1

    Google Scholar 

  43. Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, Bukowski RM, Ochoa AC (1993) Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. Cancer Res 53: 5613

    PubMed  Google Scholar 

  44. Fisk B, Tucker SL, Pollack MS, Flytzanis CN, Ioannides CG (1993) Characterization of T cell receptor V beta repertoire in ovarian tumor-infiltrating lymphocytes (abstract 2736). Proc Am Assoc Cancer Res 34: 459

    Google Scholar 

  45. Fleischer B (1992) Superantigens. Curr Opin Immunol 4: 392

    PubMed  Google Scholar 

  46. Fleischer B, Schrezenmeier H (1988) T cell stimulation by staphylococcal enterotoxins. J Exp Med 167: 1697

    PubMed  Google Scholar 

  47. Forster A, Huck S, Ghanem X, Lefranc MP, Rabbitts TH (1987) New subgroups in the human T cell rearranging V gamma gene locus. EMBO J 6: 1945

    PubMed  Google Scholar 

  48. Frank SJ, Engel I, Rutledge TM, Letouneur F (1991) Structure/function analysis of the invariant subunits of the t cell antigen receptor. Semin Immunol 3: 299

    PubMed  Google Scholar 

  49. Frankel WN, Rudy C, Coffin JM, Huber BT (1991) Linkage of Mls genes to endogenous mammary tumor viruses of inbred mice. Nature 349: 526

    PubMed  Google Scholar 

  50. Gansbacher B (1993) Use of IL2 transduced tumor cells as a vaccine against cancer. Abstract. Proc Am Assoc Cancer Res 34: 582

    Google Scholar 

  51. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E (1990) Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50: 7820

    PubMed  Google Scholar 

  52. Gansbacher B, Ziev K, Cravin K, Hantzopoulos PA, Bouchard B, Hougton A, Gilboa E, Golde D (1992) Retroviral gene transfer induced constitutive expression of interleukin 2 or interferon-gamma in irradiated human melanoma cells. Blood 80: 2817

    PubMed  Google Scholar 

  53. Gastl G, Finnstad CL, Guarini A, Bosl G, Gilboa E, Bander HH, Gansbacher B (1992) Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 52: 6229

    PubMed  Google Scholar 

  54. Gemlo BT, Palladino MA Jr, Jaffe HS, Espevik TP, Rayner AA (1988) Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine activated killer cells. Cancer Res 48: 5864

    PubMed  Google Scholar 

  55. Geppert TD, Davis LS, Gur H, Wacholtz MC, Lipsky PE (1990) Accessory cell signals involved in T cell activation. Immunol Rev 117: 5

    PubMed  Google Scholar 

  56. Gorga JC (1992) Structural analysis of class II major histocompatibility complex proteins. Crit Rev Immunol 11: 305

    PubMed  Google Scholar 

  57. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine activated killer cell phenomenon. I. Lysis of natural killer resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823

    PubMed  Google Scholar 

  58. Grimm EA, Ramsey KM, Mazumder A, Wilson DJ, Djeu JY, Rosenberg SA (1983) Lymphokine activated killer cell phenomenon. II. The precursor cells are serologically distinct from peripheral T lymphocytes, memory CTL and NK cells. J Exp Med 157: 884

    PubMed  Google Scholar 

  59. Haranaka K, Satomi N, Sakurai A (1984) Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice. Int J Cancer 34: 263

    PubMed  Google Scholar 

  60. Herrmann T, Romero P, Sartoris S, Paiola F, Accolla RS, Maryanski JL, MacDonald HR (1991) Staphylococcal enterotoxin dependent lysis of MHC class II negative target cells by cytotoxic T lymphocytes. J Immunol 146: 2504

    PubMed  Google Scholar 

  61. Hersey P, Edwards A, Milton G, McCarthy WH (1978) Relationship of cell-mediated cytotoxicity against melanoma cells: prognosis in melanoma patients. Br J Cancer 37: 505

    PubMed  Google Scholar 

  62. Hui KM, Sim T, Foo TT, Oei A-A (1989) Tumor rejection mediated by transfection with allogeneic class I histocompatibility gene. J Immunol 143: 3835

    PubMed  Google Scholar 

  63. Ioannides CG, Whiteside TL (1993) T cell recognition of human tumors: implications for molecular immunotherapy of cancer. Clin Immunol Immunopathol 66: 91

    PubMed  Google Scholar 

  64. Ioannides CG, Freedman RS (1991) Selective usage of TCR V beta in tumor-specific CTL lines isolated from ovarian tumorassociated lymphocytes. Anticancer Res 11: 1919

    PubMed  Google Scholar 

  65. Ioannides CG, Freedman RS, Platsoucas CD, Rashed S, Kim YP (1991) Cytotoxic T cell clones isolated from ovarian tumorinfiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells. J Immunol 146: 1700

    PubMed  Google Scholar 

  66. Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS (1991) Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites. Cancer Res 51: 4257

    PubMed  Google Scholar 

  67. Itoh K, Platsoucas CD, Balch CM (1988) Autologous tumorspecific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 168: 1419

    PubMed  Google Scholar 

  68. Jerome KR, Barnd DL, Bendt KM, Bower CM, Taylor-Papadimitriou J, McKendzie IF, Bast RC Jr, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51: 2908

    PubMed  Google Scholar 

  69. Jerome KR, Bu D, Finn OJ (1992) Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA. Cancer Res 52: 5985

    PubMed  Google Scholar 

  70. Jin YJ, Clayton LK, Howard FD, Koyasu S, Sich M, Steinbrich R, Tarr GE, Reinherz EL (1990) Molecular cloning of the CD3 zeta subunit identifies a CD3 epsilon related product in thymus derived cells. Proc Natl Acad Sci USA 87: 3319

    PubMed  Google Scholar 

  71. Jotereau F, Pandolfino M-C, Boudart D, Diez E, Dreno B, Douillard JY, Muller JY, LeMevel B (1991) High-fold expansion of human cytotoxic T-Lymphocytes specific for autologous melanoma cells for use in immunotherapy. J Immunother 10: 405

    PubMed  Google Scholar 

  72. June CH (1991) Signal transduction in T cells. Curr Opin Immunol 3: 287

    PubMed  Google Scholar 

  73. June CH, Fletcher MC, Ledbetter JA, Schieven GL, Siegel JN, Phillips AF, Samelson LE (1990) Inhibition of tyrosine phosphorylation prevents T cell receptor mediated signal transduction. Proc Natl Acad Sci USA 87: 7722

    PubMed  Google Scholar 

  74. Kan-Mitchell J, Huang XQ, Steinman L, Oskenberg JR, Harel W, Parker JW, Goedegebuute PS, Darrow TL, Mitchell MS (1993) Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy. Cancer Immunol Immunother 37: 15

    PubMed  Google Scholar 

  75. Kappler J, Herman A, Clements J, Marrack P (1992) Mutations defining functional regions of the staphylococcal enterotoxin B. J Exp Med 175: 387

    PubMed  Google Scholar 

  76. Kawakami Y, Zakut R, Topalian SL, Stotter H, Rosenberg SA (1992) Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol 148: 638

    PubMed  Google Scholar 

  77. Kelly A, Powis SH, Kerr LA, Mockridge I, Elliott T, Bastin J, Uchanska-Ziegler B, Ziegler A, Trowsdale J, Townsend A (1992) Assembly and function of the two ABC transporter proteins encoded in the human major histocompability complex. Nature 355: 641

    PubMed  Google Scholar 

  78. Kemeny MM, Alava G, Oliver JM (1992) Improving responses in hepatomas with circadian-patterened hepatic artery infusions of recombinant interleukin 2. J Immunother 12: 219

    PubMed  Google Scholar 

  79. Kimura N, Toyonaga B, Yoshikai Y, Triebel F, Debre P, Minden MD, Mak TW (1986) Sequences and diversity of the human T cell receptor beta chain variable region genes. J Exp Med 164: 739

    PubMed  Google Scholar 

  80. Knuth A, Danowski B, Oettgen HF, Old LG (1984) T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc Natl Acad Sci USA 81: 3511

    PubMed  Google Scholar 

  81. Knuth A, Wolfel T, Meyer zum Buschenfelde K-H (1991) Cellular and humoral immune responses against cancer: implications for cancer vaccines. Curr Opin Immunol 3: 659

    PubMed  Google Scholar 

  82. Konig F, Amloy WL, Coligan JE (1990) The implications of subunit interactions for the structure of the T cell receptor-CD3 complex. Eur J Immunol 20: 299

    PubMed  Google Scholar 

  83. Koo AS, Tso C-L, Shimabukuro T, Peyret SC, deKernion JB, Belldegrun A (1991) Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. J Immunother 10: 347

    PubMed  Google Scholar 

  84. Koyasu S, Lawton T, Novick D, Racny MA, Siliciano RF, Wallner BP, Reinherz EL (1990) Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T cell recognition of normal antigen. Proc Natl Acad Sci USA 87: 2603

    PubMed  Google Scholar 

  85. Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinett SM, Pinto CE, Gifford J, Davidson E, Grove B, Callahan RJ, Strauss HW (1989) Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet 1: 577

    PubMed  Google Scholar 

  86. Kronenberg M, Siu G, Hood LE, Shastri N (1986) The molecular genetics of the T cell antigen receptor and T cell antigen recognition. Annu Rev Immunol 4: 529

    PubMed  Google Scholar 

  87. Lefranc MP (1990) Organization of the human T cell receptor genes. Eur Cytokine Net 1: 121

    Google Scholar 

  88. Lefranc MP, Forster A, Baer R, Stinson MA, Rabbitts TH (1986) Diversity and rearrangement of the human T cell rearranging gamma genes: nine germline variable genes belonging to two subgroups. Cell 45: 237

    PubMed  Google Scholar 

  89. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA (1991) Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and IL2 mRNA accumulation. J Exp Med 173: 721

    PubMed  Google Scholar 

  90. Lotze MT (1994) Gene therapy of cancer: a pilot study of IL4 gene-modified tumor vaccines. Clinical protocol in progress. Pittsburgh Cancer Institute. (internal publication)

  91. Lotze MT, Finn OJ (1994) In vivo testing of the immune response to human breast, colon, and pancreatic tumor mucin. Clinical protocol in progress. Pittsburgh Cancer Institute, (internal publication)

  92. Mackensen A, Ferradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T (1993) Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53: 3569

    PubMed  Google Scholar 

  93. Mantovani A (1990) Tumor-associated macrophages. Curr Opin Immunol 2: 689

    Google Scholar 

  94. Marrack P, Kappler J (1987) The T cell receptor. Science 238: 1073

    PubMed  Google Scholar 

  95. Miescher S, Whiteside TL, Carrel S, Von Fliedner V (1986) Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136: 1899

    PubMed  Google Scholar 

  96. Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplators P, Liauzun P, Miloux B (1993) Interleukin 13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248

    PubMed  Google Scholar 

  97. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC (1992) Alterations in signal transduction molecules in T lymphocytes from tumor bearing hosts. Science 258: 1795

    PubMed  Google Scholar 

  98. Mitchell MS, Harel W, Kempf RA, Hu E, Kan-Mitchell J, Boswell WD, Dean G, Stevenson L (1990) Active specific immunotherapy for melanoma. J Clin Oncol 8: 856

    PubMed  Google Scholar 

  99. Miyatake SM, Hanada H, Yamashita J, Yamaski T, Ueda M, Namba Y, Hanaoka M (1986) Induction of human gliomaspcific cytotoxic T lymphocyte lines by autologous tumor stimulation and interleukin 2. J Neurooncol 4: 55

    PubMed  Google Scholar 

  100. Morrissey PJ, Goodwin RG, Nordan RP, Anderson D, Grabstein KH, Cosman D, Sims J, Lupton S, Acres B, Reed SG (1989) Recombinant interleukin 7, pre-B stimulatory factor, has costimulatory activity on purified mature T cells. J Exp Med 169: 707

    PubMed  Google Scholar 

  101. Mortarini R, Belli F, Parmiani G, Anichini A (1990) Cytokine-mediated modulation of HLA-class II, ICAM-1, LFA-3 and tumor-associated antigen profile of melanoma cells. Comparison with anti-proliferative activity by rIL 1-beta, rTNF-alpha, rIFN-gamma, rIL4 and their combinations. Int J Cancer 45: 334

    PubMed  Google Scholar 

  102. Mule JJ, McIntosh JK, Jablons DM, Rosenberg SA (1990) Antitumor activity of recombinant interleukin 6 in mice. J Exp Med 171: 629

    PubMed  Google Scholar 

  103. Mullen CA, Coale MM, Levy AT, Stetler-Stevenson WG, Liotta LA, Brandt S, Blaese RM (1992) Fibrosarcoma cells transduced with the IL6 gene exhibit reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res 52: 6020

    PubMed  Google Scholar 

  104. Mulligan RC (1993) The basic science of gene therapy. Science 260: 926

    PubMed  Google Scholar 

  105. Mustelin T, Coggeshall KM, Isakov N, Altman A (1990) T cell antigen receptor mediated activation of phospholipase C requires tyrosine phosphorylation. Science 247: 1584

    PubMed  Google Scholar 

  106. Muul LM, Spiess PJ, Director EP, Rosenberg SA (1987) Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 138: 989

    PubMed  Google Scholar 

  107. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R (1993) Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53: 5610

    PubMed  Google Scholar 

  108. Nitta T, Oksenberg JR, Rao NA, Steinman L (1990) Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma. Science 249: 672

    PubMed  Google Scholar 

  109. Nitta T, Sato K, Okumura K, Steinman L (1991) An analysis of T-cell-receptor variable-region genes in tumor-infiltrating lymphocytes within malignant tumors. Int J Cancer 49: 545

    PubMed  Google Scholar 

  110. Oksenberg JR, Stuart S, Begovich AB, Bell RB, Ehrlich HA, Steinman L, Bernard CCA (1990) Limited heterogeneity of rearranged T-cell-receptor V alpha transcripts in brains of multiple sclerosis patients. Nature 345: 344

    PubMed  Google Scholar 

  111. Paliard X, West SG, Lafferty JA, Clements JR, Kappler J, Marrack P, Kotzin BL (1991) Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253: 325

    PubMed  Google Scholar 

  112. Parkinson DR (1988) Interleukin 2 in cancer therapy. Semin Oncol 15: 10

    Google Scholar 

  113. Peoples G, Davey M, Schoof DD, Eberlein TJ (1993) Selective usage of TCR V beta genes in ovarian-specific CTL (abstract 2910). Proc Am Assoc Cancer Res 34: 488

    Google Scholar 

  114. Posnett DN, Schmelkin L, Bruton DA, August A, McGrath H, Mayer LF (1990) T cell antigen receptor V gene usage increases in V beta+ T cells in Crohn's disease. J Clin Invest 85: 1170

    Google Scholar 

  115. Puisieux I, Favrot MC, Pannetier C, Guillet JG, Kourilsky P, Even J (1993) Characterization of the TCR beta chain repertoire of melanoma TILs during immunotherapy VDJ rearrangement analysis (abstract 2905). Proc Am Assoc Cancer Res 34: 487

    Google Scholar 

  116. Pullen AM, Wade T, Marrack P, Kapples J (1990) Identification of the region of the T cell receptor beta chain that interacts with the selt superantigen Mls-la. Cell 61: 1365

    PubMed  Google Scholar 

  117. Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH (1993) In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83

    PubMed  Google Scholar 

  118. Ranges GE, Figari IS, Espevik T, Palladino MA (1987) Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J Exp Med 166: 991

    PubMed  Google Scholar 

  119. Ransom JH, Pelle BA, Brandhorst J, Hanna MG Jr (1993) HLA-DR and ICAM-I expression on vaccine tumor cells predict clinical response to a human colon carcinoma vaccine (abstract 2918). Proc Am Assoc Cancer Res 153: 489

    Google Scholar 

  120. Restifo NP, Spiess PJ, Karp SE, Mule JJ, Rosenberg SA (1992) A nonimmunologic sarcoma transduced with the cDNA for interferon-gamma elicits CD8+ T cells against the wild type tumor: correlation with antigen presentation capability. J Exp Med 175: 1423

    PubMed  Google Scholar 

  121. Ritz J, Schmidt RE, Michon J, Hercend T, Schlossman ST (1988) Characterization of functional surface structures on human natural killer cells. Adv Immunol 42: 181

    PubMed  Google Scholar 

  122. Roman-Roman S, Ferradini L, Azocar J, Genevee C, Hercend T, Triebel F (1991) Studies on the human T cell receptor alpha beta variable region genes. I. Identification of 7 additional V alpha subfamilies and 14 J alpha gene segments. Eur J Immunol 21: 927

    PubMed  Google Scholar 

  123. Rosenberg SA (1988) Cancer therapy with interleukin 2: immunologic manipulations can mediate the regression of cancer in humans. J Clin Oncol 6: 403

    PubMed  Google Scholar 

  124. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Lineban WM, Robertson CN, Lee RF, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin 2 or high-dose interleukin 2 alone. N Engl J Med 316: 889

    PubMed  Google Scholar 

  125. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318

    PubMed  Google Scholar 

  126. Rosenberg SA, Packard BS, Acbersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartzentruber D, Wei JP, White DE (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 319: 1676

    PubMed  Google Scholar 

  127. Rosenberg SA, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S, White DE (1989) Combination therapy with interleukin 2 and alpha-interferon for the treatment of patients with advanced cancer. J Clin Oncol 7: 1863

    PubMed  Google Scholar 

  128. Rosenberg SA, Lotze MT, Young JC, Topalian SL, Chang AE, Schwartzentruber DJ, Aebersold P, Leitman S, Linehan WM, Seipp CA, White DE, Steinberg SM (1993) Prospective randomized trial of high-dose interleukin 2 alone or in combination with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J Natl Cancer Inst 85: 622

    PubMed  Google Scholar 

  129. Rothenberg EV (1992) The development of functionally responsive T cells. Adv Immunol 51: 85

    PubMed  Google Scholar 

  130. Schuchter LM, Wohlganger JA, Fishman EK, MacDermoth ML, McGuire WP (1992) Sequential chemotherapy and immunotherapy for the treatment of metastatic melanoma. J Immunother 12: 272

    PubMed  Google Scholar 

  131. Schwartz RH (1990) A cell culture model for T lymphocyte clonal anergy. Science 248: 1349

    PubMed  Google Scholar 

  132. Schwartzentruber DJ, Topalian SL, Mancini M, Rosenberg SA (1991) Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. J Immunol 146: 3674

    PubMed  Google Scholar 

  133. Schwartzentruber DJ, Solomon D, Rosenberg SA, Topalian SL (1992) Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J Immunother 12: 1

    PubMed  Google Scholar 

  134. Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Nicolini G, Herlyn M, Parmiani G, Anichini A (1993) T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clones. J Exp Med 178: 1231

    PubMed  Google Scholar 

  135. Shimizu Y, Seventer GA van, Horgan KJ, Shaw S (1990) Costimulation of proliferative responses of resting CD4+ cells by the interaction of VLA4 and VLA5 with fibronectin or VLA6 with laminin. J Immunol 145: 59

    PubMed  Google Scholar 

  136. Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL (1991) Characterization of human autotumor-reactive T cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Cancer Res 51: 6153

    PubMed  Google Scholar 

  137. Si L, Whiteside, TL, Schade RR, Van Thiel DH (1983) Lymphocyte subsets studied with monoclonal antibodies in liver tissues of patients with alcoholic liver disease. Alcoholism. Clin Exp Res 7: 431

    Google Scholar 

  138. Sim GK, Yague J, Nelson J (1984) Primary structure of the T cell receptor alpha-chain. Nature 312: 771

    PubMed  Google Scholar 

  139. Sosman JA, Hank JA, Sondel PM (1990) In vivo activation of lymphokine activated killer activity with interleukin 2: prospects for combination therapies. Semin Oncol 17: 22

    PubMed  Google Scholar 

  140. Spertim F, Spits H, Geha RS (1991) Staphylococcal toxins deliver activation signals to human T cells via major histocompatibility class II molecules. Proc Natl Acad Sci USA 88: 7533

    PubMed  Google Scholar 

  141. Spiess PJ, Yang JC, Rosenberg SA (1987) In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. J Natl Cancer Inst 79: 1067

    PubMed  Google Scholar 

  142. Spits H (1991) Human T cell receptor gamma/delta+ T cells. Semin Immunol 3: 119

    PubMed  Google Scholar 

  143. Spits H, Yssel H, Takebc Y, Arai N, Yokota T, Lei F, Arai K, Banchereau J, DeVries JE (1987) Recombinant interleukin 4 promotes the growth of human T cells. J Immunol 139: 1142

    PubMed  Google Scholar 

  144. Stevenson FK (1994) Tumor vaccines. FASEB J 5: 2250

    Google Scholar 

  145. Storkus WJ, Lotze MT (1992) Melanoma immunogenicity: melanoma cells present both endogenously, and exogenously, derived peptides to CD8+ cytolytic T cells (abstract). J Immunother 11: 147

    Google Scholar 

  146. Tahery D, Ohmen J, Modlin R, Wyzykowski R, Sullivan L, Moy R (1992) T cell receptor beta chain repertoire of tumor infiltrating lymphocytes in basal cell carcinoma (abstract 1874). Proc Am Assoc Cancer Res 33: 314

    Google Scholar 

  147. Thompson CB, Lindstein T, Ledbetter JA, Kunkel SL, Young HA, Emerson SG, Leiden JM, June CH (1989) CD28 activation pathway regulates the production of multiple T cell derived lymphokine/cytokines. Proc Natl Acad Sci USA 86: 1333

    PubMed  Google Scholar 

  148. Thor Straten P, Scholler J, Hon-Jansen K, Zenthen J (1994) Preferential usage of T-cell receptor alpha beta variable regions among tumor infiltrating lymphocytes in primary human malignant melanomas. Int J Cancer (in press)

  149. Tilden AB, Itoh K, Balch CM (1987) Human lymphokine activated killer (LAK) cells: identification of two types of effector cells. J Immunol 138: 1068

    PubMed  Google Scholar 

  150. Topalian SL, Solomon D, Avis FP, Chang AE, Freerksen DL, Linehan WM, Lotze MT, Robertson CN, Seipp CA, Simon P, Simpson CG, Rosenberg SA (1988) Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: A pilot study. J Clin Oncol 6: 839

    PubMed  Google Scholar 

  151. Topalian SL, Solomon D, Rosenberg SA, (1989) Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142: 3714

    PubMed  Google Scholar 

  152. Townsend A, Bodmer H (1989) Antigen recognition by class I restricted T lymphocytes. Annu Rev. Immunol 7: 601

    PubMed  Google Scholar 

  153. Toyonaga B, Yoshikai Y, Vadasz V, Chin B, Mak TW (1985) Organization and sequences of the diversity, joining and constant region of the human T cell receptor beta chain. Proc Natl Acad Sci USA 82: 8624

    PubMed  Google Scholar 

  154. Traversari C, Bruggen P van der, Luesdier JF, Lurguin C, Chance P, Van Pel A, De Pleau E, Amar-Costesec A, Boon T (1992) A nonapeptide encoded by human gene MAGE1 is recognized on HLA-A1 by CTL directed against tumor antigen M22-E. J Exp Med 176: 1453

    PubMed  Google Scholar 

  155. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A (1990) Sequences encoded in the class II region of the MHC related to the “ABC” superfamily of transporters. Nature 348: 741

    PubMed  Google Scholar 

  156. Tuttle TM, McCrady CW, Inge TH, Salour M, Bear HD (1993) Gamma interferon plays a key role in T cell induced tumor regression. Cancer Res 53: 833

    PubMed  Google Scholar 

  157. Uchiyama A, Hoon DS, Morisaki T, Kaneda Y, Yuzuki DH, Morton DL (1993) Transfection of interleukin 2 gene in human melanoma cells augments cellular immune response. Cancer Res 53: 949

    PubMed  Google Scholar 

  158. Unanue ER (1984) Antigen presenting function of the macrophage. Annu Rev Immunol 2: 395

    PubMed  Google Scholar 

  159. Valteau-Couanet D, Carcelain G, Leboulaire C, Triebel F, Hercend T, Hartmann O (1993) Analysis of T cell receptor (TCR) of tumor-infiltrating lymphocytes (TILs) in neoblastoma (NB) (abstract 2906). Proc. Am Assoc Cancer Res 34: 487

    Google Scholar 

  160. Van den Eynde B, Lethe B, Van Pel A, De Plan E, Boon T (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173: 1373

    PubMed  Google Scholar 

  161. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, Plaen E de, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643

    PubMed  Google Scholar 

  162. Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S (1990) The LFA 1 ligand, ICAM 1 provides an important constimulatory signal for T cell receptor mediated activation of resting T cells. J Immunol 144: 4579

    PubMed  Google Scholar 

  163. Van Seventer GA, Shimizu Y, Shaw S (1991) Role of multiple accessory molecules in T cell activation. Curr Opin Immunol 3: 294

    PubMed  Google Scholar 

  164. Velotti F, Cippitelli M, Palmieri G, Punturieri A, Stoppacciaro A, Cusumano G, Tubaro A, Ruco L, Santoni A (1992) In vitro bladder cancer cells express interleukin 2 receptor (abstract 1793). Proc Am Assoc Cancer Res 33: 301

    Google Scholar 

  165. Veltri RW, Rodman SM, Maxim PE, Baseler MW, Sprinkle PM (1986) Immune complexes, serum proteins, cell-mediated immunity and immune regulation in patients with squamous cell carcinoma of the head and neck. Cancer 57: 2295

    PubMed  Google Scholar 

  166. Viens P, Blaise D, Stoppa AM (1992) Interleukin 2 in association with increasing doses of interferon gamma in patients with advanced cancer. J Immunother 11: 218

    PubMed  Google Scholar 

  167. Vitolo D, Zerbe T, Kanbour A, Dahl C, herberman RB, Whiteside TL (1992) Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 51: 573

    PubMed  Google Scholar 

  168. Watanabe Y (1993) Transfection of interferon gamma gene in animal tumors—a model for local cytokine production and tumor immunity. Semin Cancer Biol 3: 43

    Google Scholar 

  169. Weidmann E, Bergmann L, Hechler P, Mitrou PS (1991) Cytotoxic activity and phenotypic characteristics of lymphocyte aubsets after therapy of cancer patients with interleukin 2. Cancer Immunol Immunother 33: 398

    PubMed  Google Scholar 

  170. Weidmann E, Bergmann L, Stock J, Kirsten R, Mitrou PS (1992) Rapid cytokine release in cancer patients treated with interleukin 2. J Immunother 12: 123

    PubMed  Google Scholar 

  171. Weidmann E, Elder EM, Herberman RB, Trucco M, Whiteside TL (1994) The T-cell receptor beta chain variable region repertoire in fresh and cultured lymphocytes isolated from human malignant melanomas. In: Bergmann L, Mitrou PS (eds) Cytokines in cancer therapy. Contribution to oncology. Vol. 46, pp. 133–142. Karger. Germany

    Google Scholar 

  172. Weidmann E, Elder EM, Trucco M, Lotze MT, Whiteside TL (1993) Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int J Cancer 54: 383

    PubMed  Google Scholar 

  173. Weidmann E, Sacchi M, Plaisance S, Heo DS, Yasumura S, Lin WC, Johnson JT, Herberman RB, Azzarone B, Whiteside TL (1992) Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res 52: 5963

    PubMed  Google Scholar 

  174. Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M (1992) The T cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma. Cancer Res 52: 5913

    PubMed  Google Scholar 

  175. Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL (1993) Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes. Cancer Res 53: 4745

    PubMed  Google Scholar 

  176. Weiss A (1990) Structure and function of the T cell antigen receptor. J Clin Invest 86: 1015

    PubMed  Google Scholar 

  177. Weissman AM, Hou D, Orloff DG, Modi WS, Seuane ZH, O'Brien SJ, Klausner RD (1988) Molecular cloning and chromosomal localization of the human T cell receptor zeta chain: distinction from the molecular CD3 complex. Proc. Natl Acad Sci USA 85: 9709

    PubMed  Google Scholar 

  178. West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK (1987) Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316: 898

    PubMed  Google Scholar 

  179. Whiteside TL (1992) Tumor-infiltrating lymphocytes as antitumor effector cells. Biotherapy 5: 47

    PubMed  Google Scholar 

  180. Whiteside TL (1993) Tumor-infiltrating lymphocytes in human malignancies. Landes, Austin. Tex

    Google Scholar 

  181. Wolfel T, Klehmann E, Muller C, schutt KH, Meyer zum Buschenfelde KH, Knuth A (1989) Lysis of human melanoma cells by autologous cytolytic T cell clones: identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med 170: 797

    PubMed  Google Scholar 

  182. Woodland DL, Happ MP, Golob KJ, Palmer E (1991) An endogenous retrovirus mediating deletion of alpha beta T cells. Nature 349: 529

    PubMed  Google Scholar 

  183. Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL (1993) Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res 53: 1461

    PubMed  Google Scholar 

  184. Yasumura S, Weidmann e, Hirabayashi H, Johnson JT, Herberman RB, Whiteside TL (1994) HLA restriction and T-cell receptor Vβ gene expression of cytotoxic T lymphocytes reactive with human squamous cell carcinoma of the head and neck. Int J Cancer (in press)

  185. Yoshikai Y, Anatoniou D, Clark SP, Yanagi Y, Sangster R, Van den Elsen P, Terhorst C, Mak TW (1984) Sequence and expression of transcripts of the human T cell receptor beta chain genes. Nature 312: 521

    PubMed  Google Scholar 

  186. Zakut R, Topalian SL, Kawakami Y, Mancini M, Eliyahu S, Rosenberg SA (1993) Differential expression of MAGE-1, -2 and-3 messenger RNA in transformed and normal human cells. Cancer Res 53: 5

    PubMed  Google Scholar 

  187. Zipfel PF, Irving SG, Kelly K, Siebenlist U (1989) Complexity of the primary genetic response to mitogenic activation of human T cell. Mol Cell Biol 9: 1041

    PubMed  Google Scholar 

  188. Zocchi MR, Poggi A, Crosti F, Tongiani S, Rugarli C (1992) Signalling in human tumor infiltrating lymphocytes: the CD28 molecule is functional and is physically associated with CD45RO molecule. Eur J Cancer 28A: 749

    PubMed  Google Scholar 

  189. Zychlinski A, Joag S, Young JD-E (1988) Cytolytic mechanisms of the immune system. Curr Opin Immunol 1: 63

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Internal Medicine, J. W. Goethe University, Frankfurt/M, Germany

    Eckhart Weidmann

  2. Division of Immunogenetics, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pa., USA

    Massimo Trucco

  3. Department of Pathology and Otolaryngology, University of Pittsburg School of Medicine, W1041 Biomedical Science Tower, 211 Lothrop Street, 15213-2582, Pittsburgh, PA, USA

    Theresa L. Whiteside

  4. Pittsburgh Cancer Institute, W1041 Biomedical Science Tower, 211 Lothrop Street, 15213-2582, Pittsburgh, PA, USA

    Theresa L. Whiteside

Authors
  1. Eckhart Weidmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Trucco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Theresa L. Whiteside
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This manuscript was supported in part by the Pathology Education and Research Foundation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weidmann, E., Trucco, M. & Whiteside, T.L. Relevance of the T cell receptor for immunotherapy of cancer. Cancer Immunol Immunother 39, 1–14 (1994). https://doi.org/10.1007/BF01517174

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01517174

Key words

Search

Navigation